Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Collagen-based biodegradable matrices for localized drug delivery More
A novel non-invasive method for using carbon-13 magnetization transfer effects to determine and evaluate in vivo aspartate transaminase (AST) activity and levels in an organ, as a biomarker of disease and certain neurological disorders. More
An in vitro hepatitis C virus (HCV) replication system that is capable of producing viral particles in a culture medium More
A simple blood based assay to identify diabetic patients who are likely to develop or have early stage diabetic nephropathy has been developed at King's. This has the potential to be used regularly at diabetic clinics. More
Nanoparticles that exhibit high epithelial uptake and transepithelial transport More
Adrenomedullin peptides and antibodies, which would be useful in the development of a therapeutic or for diagnostics use More
The technology provides methods for diagnosis and treatment of conditions such as cancer, diabetes, or other conditions that are influenced by AM levels. More
A mechanism for augmenting the immune response against HEV in infected individuals More
Diabetes mellitus, a metabolic disease caused by deficiency of insulin, displays a higher or lower level of glucose concentration in blood than normal range(80-120mg/dL). More
King’s researchers and Guy’s & St Thomas’s NHS collaborators have discovered biomarkers which are diagnostic for early stage diabetic retinopathy (DR) and are also a measure of disease progression. More
Related Reports
Market Research Reports provided by reports.innovaro.com
Dec 2008 - 35 pages - $200
Dec 2010 - 15 pages - $500
Dec 2010 - 16 pages - $500
May 2011 - 15 pages - $250
Dec 2010 - 25 pages - $500
Dec 2007 - 65 pages - $3,395
Apr 2008 - 39 pages - $495
Sep 2011 - 59 pages - $99
Aug 2008 - 117 pages - $2,350
Sep 2011 - 30 pages - $250
Your selection
Browse By
- Industry sector
- Assay systems
- Diagnostic test systems
- Gene therapy
- Human diagnostics
- Human therapeutics
- Nanotechnology
- Other
- Research supplies
- Stem cells
- Therapeutic target
- Anorexia
- Anti-oxidant
- Appetite
- Bulimia nervosa
- Cachexia
- Cirrhosis
- Diabetes type I
- Diabetes type II
- Diabetic complications
- Fabry's disease
- Gallbladder disorder (other)
- Gallstones
- Gaucher's disease
- Hepatic protectors
- Hepatic protectors
- Hypercholesterolemia
- Hyperparathyroidism
- Hypertriglyceridemia
- Liver cancer
- Liver disorders (other)
- Metabolic disorder (other)
- Mineral supplement
- Obesity
- Weight loss
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us